迁延性细菌性支气管炎治疗进展及预后  

Treatment progress and prognosis of protracted bacterial bronchitis

作　　者：张建华 苏玉洁[2] Zhang Jianhua;Su Yujie(Department of Pediatrics, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200092, Chin;Department of Pediatrics, Putuo District People＇s Hospital, Shanghai 200060, China)

机构地区：[1]上海交通大学医学院附属新华医院儿科,200092 [2]上海市普陀区人民医院儿科,200060

出　　处：《中华实用儿科临床杂志》2018年第10期739-741,共3页Chinese Journal of Applied Clinical Pediatrics

摘　　要：迁延性细菌性支气管炎（PBB）是儿童慢性湿性咳嗽的重要病因。基于细菌感染是PBB的主要病原，因此，抗细菌感染治疗是主要的治疗手段。阿莫西林-克拉维酸钾作为经验性治疗的主要抗生素，建议至少使用2周以上，一般为4周，部分患儿需要6—8周。痰培养或支气管肺泡灌洗液培养阳性者，则可选用药敏试验敏感的抗生素治疗。Protracted bacterial bronchitis （PBB） is an important cause of chronic wet cough. Bacterial infection is the main pathogen of PBB, so antibacterial infection is the main treatment. As the main antibiotic of experiential treatment, Amoxicillin - elavulanate is recommended to be used for at least 2 weeks, usually 4 weeks, and 6 to 8 weeks in part. If the sputum culture or bronchoalveolar lavage fluid is positive, the selection of antibiotic therapy can be according to drug sensitivity test.

关 键 词：迁延性细菌性支气管炎 细菌感染 阿莫西林-克拉维酸钾 

分 类 号：R725.6[医药卫生—儿科]